NFKB1 and colorectal carcinoma: Using CRC cell lines and animal models, it was found that the combined use of enalapril and 5-FU greatly suppressed the NF-κB/STAT3 pathway, which restored chemosensitivity and potentiated the antitumor effects of 5-FU [37].